Abstract
This book reprots on the results of an empirical study of the Australian medical biotechnology industry, involving surveys and interviews with participants in research institutions, companies and diagnostic facilities. Despite ongoing concerns about the impact of gene and research tool patents on downstream research and development, this study reveals evidence of liberal licensing practices associated with some essential or foundational inventions within the Australian industry. However, there are also significant challenges, including negotiating difficulties, restrictive licence terms, refusals to license and stacking royalties, Hence, some consideration of options for law reform is warranted.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
